
Fluidomat (FLUIDOM) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
209.5M
Gross Profit
144.9M
69.14%
Operating Income
81.2M
38.76%
Net Income
63.9M
30.51%
Balance Sheet Metrics
Total Assets
929.7M
Total Liabilities
125.2M
Shareholders Equity
804.5M
Debt to Equity
0.16
Cash Flow Metrics
Revenue & Profitability Trend
Fluidomat Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 721.8M | 553.9M | 461.2M | 339.7M | 282.2M |
Cost of Goods Sold | 225.3M | 239.9M | 195.2M | 148.3M | 126.4M |
Gross Profit | 496.5M | 314.0M | 265.9M | 191.4M | 155.8M |
Gross Margin % | 68.8% | 56.7% | 57.7% | 56.3% | 55.2% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 33.2M | 25.4M | 27.7M | 16.0M |
Other Operating Expenses | 94.8M | 11.2M | 9.2M | 7.1M | 5.4M |
Total Operating Expenses | 94.8M | 44.4M | 34.5M | 34.8M | 21.4M |
Operating Income | 263.5M | 145.5M | 118.6M | 57.0M | 44.3M |
Operating Margin % | 36.5% | 26.3% | 25.7% | 16.8% | 15.7% |
Non-Operating Items | |||||
Interest Income | - | 23.5M | 12.1M | 13.2M | 12.6M |
Interest Expense | 0 | 1.0K | 9.0K | 31.0K | 226.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 298.1M | 175.7M | 128.7M | 74.1M | 54.0M |
Income Tax | 75.8M | 45.2M | 32.5M | 19.4M | 14.1M |
Effective Tax Rate % | 25.4% | 25.7% | 25.3% | 26.1% | 26.1% |
Net Income | 222.2M | 130.5M | 96.2M | 54.8M | 39.9M |
Net Margin % | 30.8% | 23.6% | 20.9% | 16.1% | 14.1% |
Key Metrics | |||||
EBITDA | 307.4M | 187.1M | 138.3M | 79.1M | 63.0M |
EPS (Basic) | - | ₹26.49 | ₹19.53 | ₹11.65 | ₹8.09 |
EPS (Diluted) | - | ₹26.49 | ₹19.53 | ₹11.65 | ₹8.09 |
Basic Shares Outstanding | - | 4927000 | 4927000 | 4927000 | 4927000 |
Diluted Shares Outstanding | - | 4927000 | 4927000 | 4927000 | 4927000 |
Income Statement Trend
Fluidomat Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 4.3M | 10.3M | 20.5M | 17.3M | 6.5M |
Short-term Investments | 215.0M | 114.1M | 32.5M | 36.6M | 46.1M |
Accounts Receivable | 224.6M | 134.7M | 136.5M | 107.1M | 89.2M |
Inventory | 51.7M | 64.5M | 64.2M | 47.8M | 55.0M |
Other Current Assets | 4.7M | 2.7M | 1.5M | -2.0K | 7.5M |
Total Current Assets | 501.6M | 377.2M | 260.9M | 250.6M | 208.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | 117.4M | 79.5M | 72.4M | 83.5M | 65.6M |
Goodwill | 1.0M | 623.0K | 191.0K | 365.0K | 580.0K |
Intangible Assets | 1.0M | 623.0K | 191.0K | 365.0K | 580.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 6.3M | 6.3M | 7.6M | 1.0K | 2.7M |
Total Non-Current Assets | 428.1M | 334.0M | 338.7M | 261.3M | 241.1M |
Total Assets | 929.7M | 711.2M | 599.6M | 511.9M | 449.4M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 32.5M | 40.2M | 41.7M | 46.4M | 35.7M |
Short-term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 65.0M | 33.6M | 22.5M | 19.6M | 17.2M |
Total Current Liabilities | 110.8M | 89.1M | 95.5M | 87.5M | 68.2M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | - | - |
Deferred Tax Liabilities | 2.4M | 1.9M | 2.0M | 2.5M | 1.9M |
Other Non-Current Liabilities | - | - | -1.0K | - | - |
Total Non-Current Liabilities | 14.4M | 12.9M | 11.8M | 11.2M | 9.4M |
Total Liabilities | 125.2M | 102.1M | 107.4M | 98.7M | 77.6M |
Equity | |||||
Common Stock | 49.3M | 49.3M | 49.3M | 49.3M | 49.3M |
Retained Earnings | - | 437.0M | 330.1M | 257.0M | 229.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 804.5M | 609.1M | 492.2M | 413.2M | 371.8M |
Key Metrics | |||||
Total Debt | 0 | 0 | 0 | 0 | 0 |
Working Capital | 390.8M | 288.0M | 165.3M | 163.1M | 140.1M |
Balance Sheet Composition
Fluidomat Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 298.1M | 175.7M | 128.7M | 70.8M | 54.0M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -78.8M | 3.0M | -49.2M | -9.1M | -12.0M |
Operating Cash Flow | 190.1M | 155.3M | 67.4M | 48.6M | 29.6M |
Investing Activities | |||||
Capital Expenditures | 0 | 0 | 486.0K | 19.0K | 880.0K |
Acquisitions | 0 | 1.7M | 0 | - | - |
Investment Purchases | -92.3M | -112.5M | -44.7M | -27.1M | -19.7M |
Investment Sales | 5.8M | 13.2M | 0 | - | - |
Investing Cash Flow | -86.6M | -97.7M | -38.0M | -27.1M | -18.8M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -27.1M | -22.2M | -17.2M | -16.0M | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | 0 | 0 | -8.4M |
Financing Cash Flow | -27.1M | -22.2M | -17.2M | -16.0M | -16.7M |
Free Cash Flow | 78.6M | 86.1M | 47.9M | 40.8M | 17.8M |
Net Change in Cash | 76.5M | 35.4M | 12.2M | 5.5M | -5.9M |
Cash Flow Trend
Fluidomat Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
24.27
Price to Book
7.03
Price to Sales
7.83
Profitability Ratios
Profit Margin
29.95%
Operating Margin
22.48%
Return on Equity
27.62%
Return on Assets
23.90%
Financial Health
Current Ratio
4.53
Debt to Equity
0.00
Beta
0.74
Per Share Data
EPS (TTM)
₹45.17
Book Value per Share
₹156.05
Revenue per Share
₹144.58
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
fluidom | 5.4B | 24.27 | 7.03 | 27.62% | 29.95% | 0.00 |
SKF India | 219.3B | 41.67 | 8.44 | 21.78% | 10.51% | 0.27 |
Timken India | 213.3B | 46.95 | 7.50 | 15.73% | 14.35% | 0.58 |
Kennametal India | 47.9B | 46.51 | 6.15 | 13.77% | 8.86% | 0.32 |
Harsha Engineers | 37.2B | 40.66 | 2.99 | 7.12% | 6.38% | 15.98 |
Wendt India | 19.7B | 55.25 | 8.09 | 16.20% | 15.02% | 0.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.